Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

AUROBINDO PHARMA LTDAUROBINDO PHARMA LTD
VS
Torrent Pharmaceuticals LtdTorrent Pharmaceuticals Ltd
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District,, Hyderabad, 500032, IN

Last Update: 03/04/2026

View Profile
Between 750 and 799
https://www.aurobindo.com/
778/1000Fair

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, brand...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,862
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd, Ahmedabad, 380015, IN

Last Update: 02/04/2026

View Profile
Between 750 and 799
http://www.torrentpharma.com
789/1000Fair

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:11,552
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for AUROBINDO PHARMA LTD in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Torrent Pharmaceuticals Ltd in 2026.

Incidents

Incident History - AUROBINDO PHARMA LTD (X = Date, Y = Severity)

AUROBINDO PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Torrent Pharmaceuticals Ltd (X = Date, Y = Severity)

Torrent Pharmaceuticals Ltd cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD

Incidents
No explicit notable incidents reported.
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Incidents
No explicit notable incidents reported.

FAQ

Between AUROBINDO PHARMA LTD company and Torrent Pharmaceuticals Ltd company, which one has the best AI Cybersecurity Score ?
Between AUROBINDO PHARMA LTD company and Torrent Pharmaceuticals Ltd company, which one has experienced more cyber incidents in the past ?
Between AUROBINDO PHARMA LTD company and Torrent Pharmaceuticals Ltd company, which one has experienced more cyber incidents this year ?
Between AUROBINDO PHARMA LTD company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one ransomware attack ?
Between AUROBINDO PHARMA LTD company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one data breach ?
Between AUROBINDO PHARMA LTD company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one targeted cyberattack ?
Between AUROBINDO PHARMA LTD company and Torrent Pharmaceuticals Ltd company, which one has experienced at least one vulnerability ?
Between AUROBINDO PHARMA LTD company and Torrent Pharmaceuticals Ltd company, which one holds the most compliance certifications ?
Between AUROBINDO PHARMA LTD company and Torrent Pharmaceuticals Ltd company, which one holds the fewest compliance certifications ?
Between AUROBINDO PHARMA LTD company and Torrent Pharmaceuticals Ltd company, which one has the most subsidiaries ?
Between AUROBINDO PHARMA LTD company and Torrent Pharmaceuticals Ltd company, which one has the largest number of employees ?
Between AUROBINDO PHARMA LTD and Torrent Pharmaceuticals Ltd, which company holds both SOC 2 Type 1 certifications ?
Between AUROBINDO PHARMA LTD and Torrent Pharmaceuticals Ltd, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - AUROBINDO PHARMA LTD or Torrent Pharmaceuticals Ltd ?
Which company is PCI DSS compliant - AUROBINDO PHARMA LTD or Torrent Pharmaceuticals Ltd ?
Between AUROBINDO PHARMA LTD and Torrent Pharmaceuticals Ltd, which company complies with HIPAA regulations for healthcare data ?
Between AUROBINDO PHARMA LTD and Torrent Pharmaceuticals Ltd, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-66339
SUMMARY

A flaw was found in libsoup. After a CONNECT tunnel is established through an HTTP proxy, libsoup incorrectly attaches the Proxy-Authorization header to subsequent HTTPS requests sent through that tunnel to the destination server. This allows the destination server to capture proxy credentials, leading to information disclosure.

PUBLISHED
Date2026-07-24
UPDATED
Date2026-07-24
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-66338
SUMMARY

A flaw was found in libsoup. The chunked transfer encoding parser uses a permissive parsing function for chunk sizes that silently accepts inputs violating RFC 9112, including leading whitespace, plus sign prefixes, and trailing invalid characters. When libsoup operates behind a strict frontend proxy, this parsing differential can be exploited to smuggle HTTP requests.

PUBLISHED
Date2026-07-24
UPDATED
Date2026-07-24
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:L/I:L/A:N
IMPACT SCORE
2.7
EXPLOITABILITY
2.2
CVE-2026-66337
SUMMARY

A flaw was found in libsoup. An unsigned integer underflow in the soup_filter_input_stream_read_until() function causes a heap buffer over-read when parsing multipart HTTP responses. A malicious HTTP server can exploit this by sending a crafted multipart response, potentially causing the client application to crash or disclose sensitive heap memory.

PUBLISHED
Date2026-07-24
UPDATED
Date2026-07-24
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:L
IMPACT SCORE
2.5
EXPLOITABILITY
3.9
CVE-2026-61892
SUMMARY

Weintek cMT3092X HMI allows a non-privileged user to modify tokens to escalate privileges.

PUBLISHED
Date2026-07-24
UPDATED
Date2026-07-24
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-61886
SUMMARY

Weintek cMT3092X HMI stores user account passwords in plaintext.

PUBLISHED
Date2026-07-24
UPDATED
Date2026-07-24
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8